Article ID Journal Published Year Pages File Type
10745917 Parkinsonism & Related Disorders 2013 14 Pages PDF
Abstract
There are some promising results suggesting the potential applicability of ST-Oct as a biomarker in PD. Furthermore, these data raise some interesting neurobiological questions. However, there are identifiable pitfalls before OCT quantification may be used as a biomarker in PD. Analysis standardisation is needed on a larger than existing healthy and patient population. Furthermore, longitudinal studies are needed. The exact relationship between retinal foveal deficits and visuo-cognitive impairment in PD remains a challenging research question.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Ageing
Authors
,